Boron‐10 carriers and their applications in boron neutron capture therapy
Summary of different types of boron drugs. Abstract Boron neutron capture therapy (BNCT) has emerged as a promising therapeutic modality in cancer treatment, demonstrating the ability to selectively eliminate cancer cells through the 10B(n,α)7Li nuclear reaction with minimal side effects on normal tissues.
Dachao Tang +7 more
wiley +1 more source
We present a data‐driven framework that combines experimental and computational information to accelerate the discovery of high‐performance divalent hydride solid‐state electrolytes, enabling precise predictions of activation energies and novel ionic migration mechanisms which are essential for next‐generation energy storage technology.
Qian Wang +11 more
wiley +2 more sources
Tethered N-Heterocyclic Carbene-Carboranes: Unique Ligands that Exhibit Unprecedented and Versatile Coordination Modes at Rhodium [PDF]
Four brand new hybrid ligands combining an N-heterocyclic carbene tethered with two isomeric nido-dicarbaundecaborane dianions, a neutral closo-dicarbadodecaborane or a closo-dicarbadodecaborane anion are described.
Fox, MA +3 more
core +3 more sources
Hemorrhage in mouse tumors induced by dodecaborate cluster lipids intended for boron neutron capture therapy [PDF]
The potential of boron-containing lipids with three different structures, which were intended for use in boron neutron capture therapy, was investigated. All three types of boron lipids contained the anionic dodecaborate cluster as the headgroup.
Detlef Gabel +8 more
core +2 more sources
Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells. [PDF]
Owing to the involvement of cyclooxygenase-2 (COX-2) in carcinogenesis, COX-2-selective inhibitors are increasingly studied for their potential cytotoxic properties. Moreover, the incorporation of carboranes in structures of established anti-inflammatory
Buzharevski, Antonio +10 more
core +1 more source
Boron Neutron Capture Therapy at a Crossroads: Translational Gap and Emerging Delivery Agents
This review surveys recent advances in boron delivery agents for BNCT, emphasizing the shift from classical small molecules to multifunctional nanocarriers and theranostic systems. By integrating targeting, imaging, and therapy, next‐generation boron compounds aim to bridge the gap between (bio)chemical innovation and clinical translation.
Christoph Selg, Evamarie Hey‐Hawkins
wiley +1 more source
Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue [PDF]
All over the world, societies are facing rapidly aging populations combined with a growing number of patients suffering from Alzheimer’s disease (AD). One focus in pharmaceutical research to address this issue is on the reduction of the longer amyloid-β (
Basset, Gabriele +9 more
core +1 more source
Sviluppo e applicazioni della boron neutron capture therapy [PDF]
La Boron Neutron Capture Therapy è una tecnica terapeutica altamente selettiva, utilizzata in oncologia, che si basa sulla reazione di cattura neutronica 10B(n,α)7Li .
Guidi, Claretta
core
ABSTRACT Targeted radioligand therapy has emerged as a promising treatment option for eradicating advanced cancer forms. α‐Emitters are considered particularly promising as they can obliterate (micro)‐metastases. The α‐emitter astatine‐211 (211At) has experienced increased interest due to its favorable decay properties.
Marius Müller +5 more
wiley +1 more source
Synthesis, Characterization and Evaluation of Central Nervous System Targeted Metallocarborane Complexes [PDF]
A series of new methodologies to link a neurotransmitter receptor targeting vector (WAY) to carboranes and the preparation of the corresponding metallocarboranes (M = Re, 99mTc) as a new class of organometallic CNS imaging probes is described.
Louie, Anika S.
core

